STOCK TITAN

Henry Schein SEC Filings

HSIC Nasdaq

Welcome to our dedicated page for Henry Schein SEC filings (Ticker: HSIC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Henry Schein, Inc. (NASDAQ: HSIC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a FORTUNE 500 and S&P 500® health care solutions company listed on the Nasdaq Global Select Market, Henry Schein uses its filings to report financial results, governance changes, and other material events relevant to shareholders and analysts.

Henry Schein’s current reports on Form 8-K offer timely updates on topics such as quarterly and year-to-date financial performance, leadership transitions, and key corporate announcements. For example, recent 8-K filings have furnished press releases reporting financial results for specific quarters and have disclosed changes in senior leadership, including the planned retirement of the Chief Executive Officer from that role and related succession planning.

In addition to 8-Ks, investors typically look to Henry Schein’s annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed information on its Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments. These periodic reports, referenced in company news releases, contain discussions of operations, financial condition, risk factors, and litigation matters, as well as commentary on strategic initiatives and partnerships such as the Strategic Partnership Agreement with KKR Hawaii Aggregator L.P.

Stock Titan enhances these filings with AI-powered summaries that help explain complex disclosures in clear language. Instead of reading entire documents, users can review concise explanations of key points, including segment performance, risk factor highlights, and notable changes in capital allocation or governance. Real-time updates from the EDGAR system mean that new Henry Schein filings, such as 8-Ks reporting financial results or leadership changes, appear promptly on this page.

For those tracking insider activity and executive arrangements, Form 4 and 8-K disclosures relating to departures, appointments, and compensatory arrangements provide additional context on management and board-level decisions. By combining raw filings with AI-generated insights, this page helps investors, researchers, and health care market participants interpret Henry Schein’s regulatory reporting more efficiently.

Rhea-AI Summary

Henry Schein, Inc. appointed Frederick Lowery as its new Chief Executive Officer, effective March 2, 2026, and expanded the Board from 14 to 15 members to add him as a director. Longtime CEO Stanley M. Bergman will remain in place until Mr. Lowery starts and will then continue as Chairman of the Board.

Under his employment agreement, Mr. Lowery will receive a base salary of $1,250,000 and a target annual bonus opportunity of at least 150% of base salary, with 2026 bonus metrics based 70% on earnings per share and 30% on a strategic scorecard. For fiscal 2026, his annual bonus payout will be at least $1,875,000, and he is slated to receive 2026 equity awards with a target grant-date value of $10,000,000 split among stock options, time-based restricted stock units, and performance-based restricted stock units.

He will also receive a one-time cash bonus of $1,184,000 and a special sign-on equity award of $2,500,000 in restricted stock units, plus up to $500,000 in reimbursed relocation expenses. The company amended and restated its Executive Severance Plan so that the Chief Executive Officer is eligible for severance and change-in-control protections, and adopted Fifth Amended and Restated By-Laws, both of which are filed as exhibits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Henry Schein Inc. reported an insider share transaction by executive Andrea Albertini, CEO, Global Distribution & Technology. On December 10, 2025, she surrendered 2,032 shares of common stock at $75.88 per share to the company.

The filing explains that these shares were surrendered to cover tax withholding arising from the vesting of her December 10, 2021 grant of time-based restricted stock units, which vested on December 10, 2025. After this tax-related transaction, she directly beneficially owns 65,900 shares of Henry Schein common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Henry Schein Inc. (HSIC) Chairman and CEO Stanley M. Bergman reported two stock gifts of common shares. On November 24, 2025, he gifted 140 shares of Henry Schein common stock, and on November 25, 2025, he gifted another 500 shares, each transaction coded as a "G" (gift) at a reported price of $0.00 per share.

Following these transactions, Bergman directly holds 320,377 shares of Henry Schein common stock. He also has indirect beneficial ownership of 465,961 shares through his spouse’s trusts and entities, and an additional 9,788 equivalent shares through the company’s 401(k) savings plan unitized stock fund, which reflects Henry Schein stock and cash equivalents.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Henry Schein, Inc. executive Michael S. Ettinger, who serves as Executive Vice President & Chief Operating Officer, reported a change in his ownership of Henry Schein common stock on a Form 4. On November 19, 2025, he disposed of 71 shares of common stock in a transaction coded "G," which is identified as a gift with a reported price of $0. After this transaction, he beneficially owned 101,622 shares of Henry Schein common stock directly and an additional 210 equivalent shares indirectly through the Henry Schein, Inc. 401(k) Savings Plan, where his interest is held in a unitized stock fund that combines Henry Schein stock with cash or cash equivalents.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Henry Schein (HSIC) disclosed a Form 4 showing Chairman and CEO Stanley M. Bergman made a gift of 1,030 shares of common stock on November 13, 2025 (transaction code G, price $0).

Following the transaction, Bergman beneficially owned 320,517 shares directly, 465,961 shares indirectly through spouse-related entities, and 9,788 equivalent shares via the Henry Schein 401(k) Savings Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Henry Schein, Inc. filed its Q3 2025 10-Q, reporting steady growth and active portfolio moves. Net sales were $3,339 million versus $3,174 million a year ago, with operating income of $164 million. Net income attributable to Henry Schein was $101 million, and diluted EPS was $0.84 (vs. $0.78).

By segment in the quarter, net sales were $2,835 million in Global Distribution and Value-Added Services, $331 million in Global Specialty Products, and $173 million in Global Technology. For the first nine months, net sales reached $9,747 million and operating income was $490 million.

The balance sheet showed $11,097 million in total assets. Long-term debt rose to $2,153 million and bank credit lines to $913 million. The company completed acquisitions in 2025 with total consideration of $290 million, including $112 million in cash, and recognized gains from remeasuring prior stakes. As of October 27, 2025, shares outstanding were 117,724,807.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.78%
Tags
quarterly report
Rhea-AI Summary

Henry Schein, Inc. (HSIC) furnished an update on its business by issuing a press release with financial results for the three and nine months ended September 27, 2025. The press release is attached as Exhibit 99.1 and was provided under Item 2.02.

The information described is furnished to the SEC and is not deemed filed under the Securities Exchange Act of 1934.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.78%
Tags
current report
-
Rhea-AI Summary

Stanley M. Bergman, Chairman and CEO of Henry Schein, reported a gift transaction of Henry Schein common stock on 09/10/2025. The Form 4 shows 550 shares were disposed as a gift (transaction code G). After the reported transaction, Mr. Bergman beneficially owned 321,547 shares directly. He also reported 465,961 shares held indirectly by his spouse and 9,789 equivalent shares through the company 401(k) plan based on the plan's unitized stock fund value as of the same date. The filing was signed by an attorney-in-fact on behalf of Mr. Bergman on 09/11/2025. The Form's footnotes explain the composition of spouse-held trusts and how the 401(k) equivalent shares were calculated using the closing price on 09/10/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Henry Schein, Inc. reported a leadership change involving longtime executive James Breslawski. As previously disclosed, he moved from President to Senior Advisor and member of the Executive Management Committee on April 1, 2025. On September 5, 2025, he transitioned out of this Senior Advisor role and is no longer serving in that position. The company states that, in connection with this transition, Mr. Breslawski will receive payments and benefits provided under Henry Schein’s Executive Severance Plan, which governs how senior executives are compensated when they leave qualifying roles.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
current report
Rhea-AI Summary

This Amendment No. 4 to the Schedule 13D reports that a group of KKR-related entities and individuals beneficially own 17,583,918 shares of Henry Schein, Inc. common stock, representing approximately 14.5% of the company's outstanding common stock based on 121,268,398 shares outstanding as of July 28, 2025. The reported holdings comprise 15,263,662 shares held directly by KKR Hawaii Holdings L.P., 1,931,886 shares KKR Hawaii Aggregator L.P. has the right to acquire under total return swaps (including a disclosed August Swap), and 388,370 shares held by MH Sub I, LLC.

The filing discloses that on August 6, 2025 KKR Hawaii Aggregator L.P. entered an August Swap covering 1,874,538 notional shares at an initial notional price of $66.19 per share. In connection with a Margin Loan Agreement dated August 14, 2025, KKR Hawaii Holdings L.P. borrowed $300,000,000, pledged 15,263,662 shares as collateral, and the loan is expected to mature around August 14, 2028. KKR entities executed joinder and registration-rights agreements related to those holdings. The Schedule 13D remains otherwise unchanged except as amended.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of Henry Schein (HSIC)?

The current stock price of Henry Schein (HSIC) is $78.94 as of January 21, 2026.

What is the market cap of Henry Schein (HSIC)?

The market cap of Henry Schein (HSIC) is approximately 9.2B.
Henry Schein

Nasdaq:HSIC

HSIC Rankings

HSIC Stock Data

9.15B
100.86M
0.87%
114.26%
7.09%
Medical Distribution
Wholesale-medical, Dental & Hospital Equipment & Supplies
Link
United States
MELVILLE

HSIC RSS Feed